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Vaccines are a great scientific conquest of the modern
era having made it possible to prevent many infectious
diseases that previously had a significant impact on the
population both in terms of morbidity and sequelae
and/or lethality. They act respecting/enhancing physio-
logical capabilities of the organism and have a very
favorable pharmacoeconomic profile. The development
and availability of a safe, well-tolerated and effective vac-
cine is the indispensable premise for the primary pre-
vention through vaccination in the community. Then it
is necessary to define the target to be pursued; this lat-
ter can be control, elimination and eradication. The
choice of the target is influenced by several factors;
however, it must be followed by the development of an
appropriate strategy to achieve the necessary vaccine
coverage rate. The vaccination schedule is therefore the
instrument by which each vaccine strategy is planned,
and should take into account some epidemiological,
immunological and practical requirements (Table 1) [1].
The immunization schedule is therefore the chronologi-
cal sequence of each vaccination; it is an essential tool
to achieve established targets as well as a useful guide
for any stakeholder (e.g. health care professionals, users,
ect.). The current vaccine schedule results from a series
of laws relating to compulsory vaccinations and has
been integrated over time by including recommended
immunizations [2]. A key point is that the schedule
should be a flexible instrument and continuously
updated. The Italian immunization schedule has many
positive aspects as it is updated based on the availability
of new vaccines, combines mandatory and recom-
mended immunizations (stressing in this way the rele-
vance of both types of vaccinations), is structured so
that it can be integrated in case of new epidemiological
requirements and covers all age groups. Besides, it
includes vaccines considered of priority from the public
health point of view and for this free of charge and
actively offered.
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Table 1 Immunizations schedule: main factors that should be taken into account
Epidemiological factors
• Typical age of acquistion of the disease (immunization should come first)
• Possible age-related complications of the disease
• Age-related adverse events of immunizaton
• Already implemented immunization programs
Immunological factors
• Immune system development
• Clearance of maternal antibodies
• Number of doses and time interval between doses necessary to obtain an effective immune response
• Duration of immune protection elicited by immunization
Practical factors
• Number of immunizations to be included in the schedule
• Availability of combined vaccines
• Number of vaccination sessions
• Organization of immunization services
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Concerning the paediatric age, particularly the first year
of life, the definition of the schedule should take into
account the development of the immune system, the
clearance of maternal antibodies, the typical age of acqui-
sition of infection, the possible age-related complications
of a disease, the possible side effects of immunization
according to age of immunization, the duration of elicited
immune protection, the number of appointments for vac-
cination sessions and the accessibility to vaccination ser-
vices. The scientific societies SItI and SIP, togheter with
FIMP and FIMMG, has approved the “2014 Lifetime
Immunization Schedule” (Table 2) [3].
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Table 2 2014 Lifetime Immunization Schedule up to 15 months of age (SItI, SIP, FIMP, FIMMG) (modified from ref. 3)
Vaccine 0-30 days 3 months 4 months 5 months 6 months 7 months 11 months 13 months 15 months
DTPa DTaP DTaP DTaP^
IPV IPV IPV IPV^
HBV HBV* HBV HBV HBV
Hib Hib Hib Hib




Men C conjugate Men C** or Men ACWY**





^ a fourth dose has to be provided at 5-6 years of age; for the fourth dose dTap could be used instead of DTaP if a high coverage rate is guaranteed
* newborns from HBaAg positive mother; co-administration of IgG at birth
^^ children starting immunization during the second year of life should receive two doses. One dose in the case of immunization started in the third year of life.
One dose of PCV13 is recommended for unimmunized children or for those who have been immunized with PCV7. Two doses are recommended for children at
risk
§ a second dose has to be provided at 5-6 years of age
** a second dose is recommended at 12-14 years of age: in subjects at risk immunization could start at 3 months of age (3rd dose after one year of age)
§§ schedule 3+1 in newborns; the fourth dose at 13-15 months of age
°° subjects at risk and/or attending kindergarten or communities
## recommended as universal vaccination. Could be co-administered to any other immunization of the first months of life
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